BRC Documents
NOME Objectives
SAB membership 2024
SAB talks schedule
Patient and Public Involvement and Engagement Award Request
Wednesday 4th Dec 2024
Latest News See all news>>
Start of new trial of LB54640, an oral MC4R agonist, in patients with hypothalamic obesity due to acquired hypothalamic injury
We would like to thank colleagues who refer patients to GOOS, research collaborators, funding bodies, former members of the GOOS team and the patients, families and volunteers who support our research.
Contact Us
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
University of Cambridge Metabolic Research Laboratories
Level 4, Institute of Metabolic Science
Box 289, Addenbrooke's Hospital
Cambridge, CB2 0QQ
